122 filings
424B3
BNTC
Benitec Biopharma Inc
29 May 24
Prospectus supplement
4:32pm
EFFECT
BNTC
Benitec Biopharma Inc
29 May 24
Notice of effectiveness
12:15am
S-1
BNTC
Benitec Biopharma Inc
IPO registration
15 May 24
7:32pm
8-K
BNTC
Benitec Biopharma Inc
13 May 24
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
8:05am
10-Q
2024 Q3
BNTC
Benitec Biopharma Inc
Quarterly report
13 May 24
8:01am
D
5qixby1yzexbxr4h5cr
25 Apr 24
$40.00 mm in equity / options / securities to be acquired, sold $40.00 mm, 17 investors
4:11pm
8-K
jme8 gcis
18 Apr 24
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
9:45pm
8-K
jwvsro1 zh
18 Apr 24
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
8:53am
8-K
p5bqmhus34i5f89
8 Mar 24
Departure of Directors or Certain Officers
4:17pm
EFFECT
24knxx6iq epqzdtyf
6 Mar 24
Notice of effectiveness
12:15am
8-K
2s0a5om7d1iilfi1i
13 Feb 24
Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
8:15am
S-8
vq2vh 37ikc
22 Dec 23
Registration of securities for employees
8:02pm
8-K
afdotfrx qus86lk9
7 Dec 23
Departure of Directors or Certain Officers
4:15pm
8-K
1nmp ckb6x9yq2aj8u
30 Nov 23
Benitec Biopharma Announces First Subject Dosed in Phase
7:31am
8-K
laiw4fgdxw hk
13 Nov 23
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update
8:03am
DEFA14A
98rh24pmoryddcxm5
20 Oct 23
Additional proxy soliciting materials
4:31pm